Opexa Therapeutics
Biotechnology Research • 
The Woodlands, Texas, United States • 21-50 Employees
Company overview
| Headquarters | Opexa Therapeutics, Inc., 2635 Technology Forest Blvd, The Woodlands, Texas 77381, US |
| Phone number | +12812729331 |
| Website | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
Key Contacts at Opexa Therapeutics
Mary Riser
Director
Brian Newsom
Senior Director Of R&D
Jacqaine Jackson
Director
Peter Spence
Chief Executive Officer
Opexa Therapeutics Email Formats
Opexa Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
About Opexa Therapeutics
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis as well as other autoimmune diseases, such as neuromyelitis optica. These therapies are based on Opexa's proprietary T-cell technology. The Company’s leading therapy candidate, Tcelna®, is a personalized T-cell immunotherapy in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive Multiple Sclerosis. Top-line results from the Abili-T trial are expected in early 4th quarter of 2016. Opexa’s mission is to lead the field of Precision Immunotherapy® by aligning the interests of patients, employees and shareholders.
Opexa Therapeutics revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $108,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | $650,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Opexa Therapeutics has 9 employees across 6 departments.
Departments
Number of employees
Opexa Therapeutics Tech Stack
Discover the technologies and tools that power Opexa Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
JavaScript libraries
RUM
Analytics
Web frameworks
JavaScript libraries
United Kingdom
Frequently asked questions
4.8
40,000 users
